Translating PK & Dosimetry for Faster, Safer Phase 0/FIH Progression

9:15 am - Wednesday 25th February 2026

  • Defining ABD147 PK and tumor uptake in murine DLL3 models
  • Translating preclinical dosimetry to human PBPK projections
  • Informing FIH dosing through interspecies PK/dosimetry scaling

New Company for 2026

Speakers:

Chief Scientific Officer
Abdera Therapeutics